| Year |
Citation |
Score |
| 2014 |
Zeng C, Rothfuss JM, Zhang J, Vangveravong S, Chu W, Li S, Tu Z, Xu J, Mach RH. Functional assays to define agonists and antagonists of the sigma-2 receptor. Analytical Biochemistry. 448: 68-74. PMID 24333652 DOI: 10.1016/J.Ab.2013.12.008 |
0.303 |
|
| 2013 |
Huang R, Griffin SA, Taylor M, Vangveravong S, Mach RH, Dillon GH, Luedtke RR. The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition. Pharmacology. 92: 84-9. PMID 23942137 DOI: 10.1159/000351971 |
0.33 |
|
| 2013 |
Mach RH, Zeng C, Rothfuss JM, Zhang J, Vangveravong S, Chu W, Tu Z, Li S. Abstract 2131: Functional assays to define agonists and antagonists of sigma-2 receptors. Cancer Research. 73: 2131-2131. DOI: 10.1158/1538-7445.Am2013-2131 |
0.346 |
|
| 2012 |
Luedtke RR, Mishra Y, Wang Q, Griffin SA, Bell-Horner C, Taylor M, Vangveravong S, Dillon GH, Huang RQ, Reichert DE, Mach RH. Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds. Acs Chemical Neuroscience. 3: 1050-62. PMID 23259040 DOI: 10.1021/Cn300142Q |
0.374 |
|
| 2012 |
Luedtke RR, Perez E, Yang SH, Liu R, Vangveravong S, Tu Z, Mach RH, Simpkins JW. Neuroprotective effects of high affinity Σ1 receptor selective compounds. Brain Research. 1441: 17-26. PMID 22285434 DOI: 10.1016/J.Brainres.2011.12.047 |
0.475 |
|
| 2011 |
Xu J, Zeng C, Chu W, Pan F, Rothfuss JM, Zhang F, Tu Z, Zhou D, Zeng D, Vangveravong S, Johnston F, Spitzer D, Chang KC, Hotchkiss RS, Hawkins WG, et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nature Communications. 2: 380. PMID 21730960 DOI: 10.1038/Ncomms1386 |
0.365 |
|
| 2011 |
Vangveravong S, Zhang Z, Taylor M, Bearden M, Xu J, Cui J, Wang W, Luedtke RR, Mach RH. Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound. Bioorganic & Medicinal Chemistry. 19: 3502-11. PMID 21536445 DOI: 10.1016/J.Bmc.2011.04.021 |
0.462 |
|
| 2010 |
Vangveravong S, Taylor M, Xu J, Cui J, Calvin W, Babic S, Luedtke RR, Mach RH. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Bioorganic & Medicinal Chemistry. 18: 5291-300. PMID 20542439 DOI: 10.1016/J.Bmc.2010.05.052 |
0.39 |
|
| 2010 |
VANGVERAVONG S, NICHOLS DE. ChemInform Abstract: Stereoselective Synthesis of trans-2-(Indol-3-yl)cyclopropylamines: Rigid Tryptamine Analogues. Cheminform. 26: no-no. DOI: 10.1002/CHIN.199545041 |
0.457 |
|
| 2009 |
Kumar R, Riddle LR, Griffin SA, Chu W, Vangveravong S, Neisewander J, Mach RH, Luedtke RR. Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats Neuropharmacology. 56: 956-969. PMID 19371586 DOI: 10.1016/J.Neuropharm.2009.01.019 |
0.332 |
|
| 2009 |
Kashiwagi H, McDunn JE, Simon PO, Goedegebuure PS, Vangveravong S, Chang K, Hotchkiss RS, Mach RH, Hawkins WG. Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma. Journal of Translational Medicine. 7: 24. PMID 19323815 DOI: 10.1186/1479-5876-7-24 |
0.327 |
|
| 2006 |
Vangveravong S, Xu J, Zeng C, Mach RH. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3α-yl carbamate analogs as σ2 receptor ligands Bioorganic and Medicinal Chemistry. 14: 6988-6997. PMID 16837201 DOI: 10.1016/J.Bmc.2006.06.028 |
0.423 |
|
| 2006 |
Vangveravong S, McElveen E, Taylor M, Xu J, Tu Z, Luedtke RR, Mach RH. Synthesis and characterization of selective dopamine D2 receptor antagonists. Bioorganic & Medicinal Chemistry. 14: 815-25. PMID 16288878 DOI: 10.1016/J.Bmc.2005.09.008 |
0.367 |
|
| 2004 |
Mach RH, Huang Y, Freeman RA, Wu L, Vangveravong S, Luedtke RR. Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14: 195-202. PMID 14684327 DOI: 10.1016/J.Bmcl.2003.09.083 |
0.434 |
|
| 1998 |
Vangveravong S, Kanthasamy A, Lucaites VL, Nelson DL, Nichols DE. Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives. Journal of Medicinal Chemistry. 41: 4995-5001. PMID 9836617 DOI: 10.1021/Jm980318Q |
0.374 |
|
| 1995 |
Vangveravong S, Nichols DE. Stereoselective synthesis of trans-2-(indol-3-yl)cyclopropylamines: Rigid tryptamine analogues Journal of Organic Chemistry. 60: 3409-3413. DOI: 10.1021/Jo00116A028 |
0.453 |
|
| Show low-probability matches. |